A significant breakthrough in cancer research is emerging with the use of VHH fragments to reactivate mutated p53. This vital cancer inhibitor protein is frequently disabled in several kinds of tumors, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research